Entrectinib-induced acute right heart failure in a patient with metastatic lung adenocarcinoma
Anno:
2024
We report a case report of a 45-year-old woman with a recent diagnosis of stage IV lung adenocarcinoma (PDL1 60%) with brain metastases, who started entrectinib 600 mg orally once daily. Four days after entrectinib initiation, the patient activated the emergency medical services for acute onset of marked fatigue…